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Abstract
Background: Although research in this area remains sparse, raising a child with some genetic disorders has been
shown to adversely impact maternal health and family quality of life. The aim of this study was to investigate such
impacts in families with a child with the CDKL5 disorder, a newly recognised genetic disorder causing severe
neurodevelopmental impairments and refractory epilepsy.
Methods: Data were sourced from the International CDKL5 Disorder Database to which 192 families with a child
with a pathogenic CDKL5 mutation had provided data by January 2016. The Short Form 12 Health Survey Version 2,
yielding a Physical Component Summary and a Mental Component Summary score, was used to measure primary
caregiver’s wellbeing. The Beach Center Family Quality of Life Scale was used to measure family quality of life.
Linear regression analyses were used to investigate relationships between child and family factors and the various
subscale scores.
Results: The median (range) age of the primary caregivers was 37.0 (24.6–63.7) years and of the children was
5.2 (0.2–34.1) years. The mean (SD) physical and mental component scores were 53.7 (8.6) and 41.9 (11.6), respectively.
In mothers aged 25–54 years the mean mental but not the physical component score was lower than population
norms. After covariate adjustment, caregivers with a tube-fed child had lower mean physical but higher mean mental
component scores than those whose child fed orally (coefficient = −4.80 and 6.79; p = 0.009 and 0.012, respectively).
Child sleep disturbances and financial hardship were negatively associated with the mental component score.
The mean (SD) Beach Center Family Quality of Life score was 4.06 (0.66) and those who had used respite services
had lower scores than those who had not across the subscales.
Conclusions: Emotional wellbeing was considerably impaired in this caregiver population, and was particularly
associated with increased severity of child sleep problems and family financial difficulties. Family quality of life
was generally rated lowest in those using respite care extensively, suggesting that these families may be more
burdened by daily caregiving.
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Background
The CDKL5 disorder is a recently identified genetic
disorder caused by mutations in the X-linked cyclin-
dependent kinase-like 5 (CDKL5) gene [1]. These muta-
tions were originally identified in children or adults who
had been clinically diagnosed with epileptic encephal-
opathy [2] or the early-onset seizure variant of Rett
syndrome (RTT) [3]. However, there has been recent
evidence demonstrating some differences in clinical fea-
tures when compared with typical RTT [4–6]. Epilepsy
is almost universal and generally occurs in early infancy
with a median age of six weeks ranging from one week
to 1.5 years [4, 7] and thus symptoms of this disorder
appear very early in life. Sleep difficulties appear to be
more common in the CDKL5 disorder than in RTT [4, 6].
Genotype-phenotype relationships have been difficult
to study because of the paucity of recurrent mutations
and the generally small case series. Our recent study
(n = 127) which examined early development in this
disorder categorised mutation types into four groups
according to the effect on protein function and found
that compared with those with no functional protein,
those with a truncating mutation after amino acid (aa)
781 were more likely to acquire motor and communi-
cation skills [8].
Growing evidence suggests that raising a child with a
disability greatly impacts the welfare of the primary
caregiver, particularly, the mother. Although there is an
increasing number of studies examining maternal
health [9, 10], research specifically targeting families
caring for a child with a genetic disorder remains rela-
tively scarce. While impaired mental health has been
reported for those with a child with Down syndrome
[11] and RTT [12, 13], and increased stress for those
with a child with Prader-Willi syndrome [14], there are
no data on the health of parents caring for a child with
the CDKL5 disorder.
The concept of family quality of life for those with a
child with a developmental disability has developed
along with understanding of the crucial role that family
plays in raising a child with a disability [15]. Identifying
specific challenges for the family is critical to providing
an inclusive and multidisciplinary healthcare strategy
[16]. The burden of care may impact more greatly on
families with a child who have more severe neurodeve-
lopmental impairments accompanied with complex co-
morbidities and this is typical in many rare disorders.
Often, the child’s diagnosis and access to syndrome-
specific family support can be considerably delayed,
adversely affecting parental wellbeing [17] and possibly
also family quality of life.
The aim of this study is to examine primary caregivers’
wellbeing and family quality of life among families with
a child living with the CDKL5 disorder, and determine
the relationships with a range of factors from child’s
characteristics through family circumstances to avail-
ability of public resources. This study is the first inves-




Prior to 2012 the international Rett syndrome database,
InterRett, set up in 2002, and mainly collecting data
using electronic data submission [4, 18], also included
cases with the CDKL5 disorder. In 2012 the Inter-
national CDKL5 Disorder Database (ICDD) was estab-
lished by recontacting those InterRett families in whose
child a CDKL5 gene mutation had been identified, and
by recruiting new cases in collaboration with the Inter-
national Foundation for CDKL5 Research (IFCR). Fol-
lowing registration on the IFCR webpage, an ICDD staff
member contacts the family, explains the study and pro-
vides instructions on how they can complete the ques-
tionnaire and provide their genetic test results. The
questionnaire comprises two primary components and
an epilepsy diary. The first part includes sections that
provide a comprehensive picture of the child’s clinical
condition from birth to present: perinatal details; pri-
mary concerns and diagnosis; developmental milestones;
regression; current functional ability, including gross
motor, communication and feeding; past and current
seizure frequency and medication; sleep difficulties;
emotional and social development; stereotypic hand
movements; gastrointestinal symptoms; skeletal and
muscular health; other comorbidities; hospitalisations;
drug treatments; stage of puberty; current body mea-
surements; equipment and intervention use; day care
and educational supports; and utilisation of respite care
and financial aids. Questions were also asked about the
specific forms of respite care used, where formal res-
pite included services provided by public or private or-
ganisations and informal respite referred to any service
offered by other family members, friends and neigh-
bours. The second part includes sections regarding
family demographics, family wellbeing using the Beach
Center Family Quality of Life (BCFQOL) Scale, and
parental wellbeing using the Short Form 12 Health
Survey Version 2 (SF-12v2).
For the current study, data were collected between
September 2012 and January 2016. Of those with a
confirmed pathogenic mutation, 192 of 209 provided
questionnaire data. One hundred and fifty-eight families
(82.2% of 192) were included in the parental health
analysis excluding 34 of those with three or more miss-
ing items. Of those, 141 (89.2%) questionnaires were
completed by the biological mother, 15 (9.5%) by the
biological father, and one (0.6%) each by a foster mother
Mori et al. Orphanet Journal of Rare Diseases  (2017) 12:16 Page 2 of 15
and a grandparent. In the family quality of life analysis,
149 families with fewer than three missing items
(77.6% of 192) were included. The questionnaires were
filled out by 131 (87.9%) biological mothers, 16 (10.7%)




There was considerable variability in mutations in the
CDKL5 gene with 149 unique and only 18 recurrent
mutations. Hence, every mutation was categorised into
one of five groups according to the subsequent protein
function: No functional protein; Missense/in-frame
mutations within kinase domain; Truncations between
aa172 and aa781; Truncations after aa781; and muta-
tions that could not be grouped [8].
Child’s functional abilities
For those aged 1.5 years or over, abilities to sit on the
floor for ten seconds and to walk ten steps were cate-
gorised as needing no assistance, needing some sup-
port or unable. Also in those aged 1.5 years or over,
ability to communicate was categorised as using no or
simple communication methods (eg, body language
and facial expressions), complex gestures and vocalisa-
tion (eg, selects or rejects a photo of object, points at
an object or returns an unwanted item) or using sign
or spoken language (eg, single words and sentences).
Children or adults who were totally dependent on en-
teral feeding were excluded from analyses relating to
dietary concerns.
Child’s sleep
The Sleep Disturbance Scale for Children (SDSC) has
been validated in children with disability as well as
healthy children [19]. It contains 26 items rated on a
five-point Likert scale [19]. Four items were not in-
cluded in the questionnaire as they were not appropri-
ate to this population (e.g. the child sleep walks). The
average score of the remaining 22 items was calculated
with a possible range of one to five among those with
no more than two missing items. Higher scores indi-
cate poorer quality of the child’s sleep and data were
stratified into quartile groups.
Child’s hospitalisations
A hospital admission rate was calculated by dividing the
total number of reported hospitalisations by the child’s
age. Data were then stratified into quartile groups.
Primary caregiver wellbeing
The SF-12v2 is a valid and reliable instrument of asses-
sing self-reported health and wellbeing [20]. It comprises
twelve items that form two scales, the Physical Compo-
nent Summary (PCS) and Mental Component Summary
(MCS), and eight subscales, including Physical Function-
ing, Role Physical, Bodily Pain, General Health, Vitality,
Social Functioning, Role Emotional and Mental Health
[20]. The score is calculated based on a norm-
referencing method using the US general norms col-
lected in 1998 with a mean score of 50 and standard
deviation (SD) of 10. Higher scores indicate better
health status. Overall, 149 individuals answered all
items, and seven and two families had one and two
missing items, respectively. For each of eight subscales,
a mean value among those without any missing data
was applied to best estimate when the subscale score
calculation resulted in failure due to the missing items.
Family quality of life
The BCFQOL Scale assesses family quality of life, specif-
ically, for those raising children with a disability [21, 22].
The instrument, originally developed in the US, has been
used in other countries including Australia and Spain
[21]. It comprises 25 items with five subscales: Family
interaction; Parenting; Emotional wellbeing; Physical/
Material wellbeing; and Disability-related support [22].
The average of total item scores is obtained for each fac-
tor, with a possible value of one to five (three and four
are rated when a family are neither satisfied or dissatis-
fied and satisfied with an item, respectively). Higher
scores indicate better family quality of life. In total, 130
families responded to every item, and 16 and three indi-
viduals had one and two missing items, respectively.
Analysis
The PCS and MCS scores of the SF-12v2, and five factor
scores of the BCFQOL Scale were the dependent vari-
ables. Univariate linear regression analyses were per-
formed to investigate their crude relationships with the
independent variables including family aspects such as
parent’s age and employment status, child’s characteris-
tics such as current functional ability and SDSC scores,
and use of social supports such as respite care services.
Multivariate linear regression analyses aimed to examine
effects of the child’s clinical symptoms and socio-
environmental factors on the SF-12v2 and BCFQOL
scores and included adjustment for potential con-
founders, including socio-demographic factors, family
composition and child’s age. These variables comprised
parent’s age, highest qualification and work status, as
well as child’s age, birth order, number of siblings, and
country of birth. Age was a continuous variable and
qualification and country of birth were binary variables
(i.e. university degree or lower, North America or others,
respectively) in the models. Multivariate linear regres-
sion models for subscales of the BCFQOL Scale included
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the PCS and MCS as continuous variables as well as all
the abovementioned adjustors because the SF-12v2
and BCFQOL scale were scored by the same family
member. Differences in mean PCS and MCS scores
between 141 biological mothers and the US female
norms were assessed using t-tests. The statistical pack-
age Stata 14 (StataCorp LP, College Station, TX) was
used for all the analyses.
Results
Table 1 shows the child and family characteristics if the
child had a confirmed pathogenic mutation in the
CDKL5 gene, regardless of whether they fulfilled inclu-
sion criteria for the analyses. At ascertainment, bio-
logical parents ranged in age from 24.6 to 63.7 years
with a median of 38.5 years. Approximately 60% (59.4%)
had university degrees, whereas nearly half (47.5%) were
full-time homemakers or unemployed. The child’s me-
dian age was 5.2 years, varying from 0.2 to 34.1 years,
and the majority (85.4%) were females. Over half of the
children (52.4%) were born in the US, followed by the
United Kingdom (UK) and Australia (both 7.3%). More
than three quarters (77.2%) had siblings and nearly half
(46.3%) were the first child for the parents. Each of the
following mutation groups (no functional protein, mis-
sense or in-frame mutations within kinase domain, and
truncations from aa172 to aa781) accounted for between
a quarter and a third of the cases.
Over 60% (61.8%) of those aged 1.5 years or more
were able to sit on the floor without any assistance,
whereas only 21.3% were able to walk independently.
Less than one fifth (19.6%) were able to communicate
using sign or spoken language and approximately a half
(53.8%) avoided eye contact. Almost two thirds (64.1%)
currently had epileptic seizures on a daily basis. Almost
one sixth (15.8%) of the children were dependent on en-
teral nutrition and the majority (25 of 27) of this group
had a gastrostomy. More than half (52.5%) of mothers of
those whose children were orally fed, including combin-
ation use with enteral feeding, were concerned about the
amount of food and/or liquid their child consumed.
Almost three quarters (73.2%) of the families had utilised
a form of respite care services and with nearly a third
(32.7%) receiving both the informal and public services.
Nearly half (43.5%) had experienced financial hardship
to meet their child’s healthcare needs.
Primary caregiver wellbeing
The mean PCS score was 53.7 (SD 8.6) ranging from
28.0 to 72.7. The univariate analysis identified that the
child’s country of birth had the greatest variability in the
scores such that mothers of children who were born in
Australia and New Zealand, and Western European
countries had lower scores than those of children who
were born in North America (coefficients = −10.98 and
−9.21; p <0.001 and p <0.001, respectively) (Table 2).
Those whose child was dependent on enteral nutrition
had considerably poorer physical health (mean PCS
score 49.6) compared with those whose child fed orally
(mean PCS score 54.3; coefficient = −4.72; p = 0.013), as
had part-time workers (mean PCS score 50.4) compared
with full-time homemakers (mean PCS score 55.1; coef-
ficient = −4.69; p = 0.006). The negative effect of enteral
feeding remained significant in the multivariate analysis
(coefficient = −4.51; p = 0.015) (Table 3). There was slight
improvement in primary caregiver’s physical health for
those who used both forms of respite care (coefficient =
1.00; p = 0.603).
The mean MCS score was 41.9 (SD 11.6) ranging from
9.3 to 63.2. The number of children in the family,
followed by the parent’s age, had the two greatest im-
pacts in the univariate regression analysis (Table 2).
Mothers with an only child having the disorder reported
the poorest mental wellbeing with a mean of 37.4,
compared with having two, and three or more children
(coefficient = −4.47 and −7.56; p = 0.061 and 0.002,
respectively). MCS scores rose with increasing parent’s
age, with the mean score of 41.9 for those aged 30 to
40 years and 43.3 for those aged 40 years or more, com-
pared with that of 35.9 in those aged younger than
30 years (p = 0.101 and 0.048, respectively). Child fac-
tors also impacted greatly on the MCS scores. Severity
of the child’s sleep disturbances associated negatively
with a mean of 38.2 in the highest quartile (i.e. the
greatest difficulty) to 45.2 for the lowest (i.e. the least
difficulty) (p = 0.010). Mothers of children who were to-
tally dependent on enteral nutrition had the highest
MCS with a mean of 47.4, significantly higher than
those whose children were totally orally fed (p = 0.013).
Experiencing financial hardship adversely affected men-
tal health (coefficient = −4.89; p = 0.011). The multivari-
ate analysis identified that the child’s sleep disturbances
had the largest negative effect on MCS scores (coeffi-
cient = −8.04; p = 0.008, the highest vs. lowest quartile)
(Table 3). The impact of the child’s feeding pattern and
financial difficulty experiences remained considerable.
Utilisation of respite care services did not appear to be
associated with improvement in primary caregiver’s
emotional health.
The mean PCS score of 141 of biological mothers was
higher overall at 54.0 (SD 8.5), compared with 48.5 (SD
9.9) for the US female norms (p <0.001), but for those
aged 25 to 34 years the increase was minimal at 1.4
points (95%CI −1.29, 4.13). On the other hand, the mean
MCS score for CDKL5 mothers at 41.5 (SD 11.5), was
6.90 points (95%CI −8.57, −5.23) lower that of the US
female norms (p <0.001). The difference was virtually
consistent across the age groups.
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Table 1 Family demographics and the child’s characteristics in
the database (n=192)
Family factors
Parental age (n=160) mean (SD), years 38.2 (7.0)
n (%)
Under 30 years 14 (8.8)
30 to 40 years 84 (52.5)
40 years or over 62 (38.8)
Parental qualification (n=160), n (%)
11 or 12 years of school 34 (21.3)
TAFE/technical certificate 31 (19.4)
University degree 95 (59.4)
Parental work status (n=160), n (%)
Full-time homemaker/unemployment 76 (47.5)
Part-time employment 39 (24.4)
Full-time employment 45 (28.1)
Number of siblings (n=162), n (%)
0 37 (22.8)
1 67 (41.4)
2 or more 58 (35.8)
Birth order (n=162), n (%)
The first child 75 (46.3)
Laterborn 87 (53.7)
Child factors
Child’s age (n=192) mean (SD), years 7.1 (6.1)
n (%)
Under 1.5 years 30 (15.6)
1.5 to 7 years 86 (44.8)
7 to 13 years 48 (25.0)
13 years 28 (14.6)
Child’s gender (n=192), n (%)
Female 164 (85.4)
Male 28 (14.6)
Child’s country of birth (n=191), n (%)
North America 105 (55.0)
The United Kingdom 14 (7.3)
Australia and New Zealand 16 (8.4)
Western Europe 38 (19.9)
Others 18 (9.4)
Mutation group (n=192), n (%)
No functional protein 55 (28.7)
Missense/In-frame mutations within kinase domain 48 (25.0)
Truncations from aa172 to aa781 58 (30.2)
Truncations after aa781 16 (8.3)
Mutations not grouped 15 (7.8)
Feeding pattern (n=171), n (%)
Oral intake only 128 (74.9)
Combination use#2 16 (9.4)
Enteral nutrition only#3 27 (15.8)




Table 1 Family demographics and the child’s characteristics in
the database (n=192) (Continued)
Floor sitting (n=144)#5, n (%)
No assistance 89 (61.8)
Some assistance 14 (9.7)
Mximal assistance/unable 41 (28.5)
Taking 10 steps forward (n=141)#5, n (%)
No assistance 30 (21.3)
Some assistance 20 (14.2)
Mximal assistance/unable 91 (64.5)
Eye contact (n=158), n (%)
No 85 (53.8)
Yes 73 (46.2)
Communication (n=143)#5, n (%)
No/Simple communication 53 (37.1)
Complex gestures/vocalisation 62 (43.4)
Sign/Spoken language 28 (19.6)




1 to 5 times per day 74 (46.3)
At least 5 times per day 29 (18.1)
Sleep difficulties (average SDSC score) (n=155), n (%)
1 to 1.50 (1st quartile) 38 (24.5)
1.50 to 1.81 (2nd quartile) 39 (25.2)
1.81 to 2.17 (3rd quartile) 40 (25.8)
2.17 to 5 (4th quartile) 38 (24.5)
Hospitalisation rate (n=156), per 1 person-year, n (%)
0 to 0.38 (1st quartile) 39 (25.0)
0.38 to 0.86 (2nd quartile) 39 (25.0)
0.86 to 2.14 (3rd quartile) 39 (25.0)
2.14 to 13.70 (4th quartile) 39 (25.0)
Socio-environmental factors
Respite care (n=153), n(%)
None 41 (26.8)
Formal respite care only 21 (13.7)
Informal respite care only 41 (26.8)
Both formal and informal respite care 50 (32.7)
Financial difficulty (n=147), n (%)
No 83 (56.5)
Yes 64 (43.5)
#1 North America includes the United States (100) and Canada (5). Australia
and New Zealand contains Australia (14) and New Zealand (2). Western Europe
includes Germany (12), France (7), the Netherlands (6), Ireland (3), Spain (2),
Italy (2), Belgium (1), Denmark (1), Finland (1), Norway (1), Sweden (1) and
Luxemburg (1). Others comprises Brazil (3), India (2), Russia (2), Hungary (2),
Bulgaria (1), Poland (1), Slovenia (1), Israel (1), China (1), Singapore (1), Mexico
(1), Perto Rico (1) and Argentina (1).
#2 14 used a gastrostomy tube, 2 used a nasogastric tube
#3 25 used a gastrostomy tube, 2 used a nasogastric tube
#4 Among children who intook food orally with or without combination use of
external nutrition
#5 Excludes child aged younger than 1.5 years
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Mean (SD) 53.7 (8.6) Co-efficient Mean (SD) 41.9 (11.6) Co-efficient
Parent’s age 152
Under 30 years 12 53.5 (5.9) Reference 35.9 (15.7) Reference
30 to 40 years 80 54.7 (8.7) 1.23 41.9 (11.3) 5.97
40 years or over 60 52.9 (8.7) −0.59 43.3 (11.3) 7.37**
Parent’s qualification 147
11 or 12 years of school 27 53.2 (7.9) Reference 41.8 (13.2) Reference
TAFE/Technical certificate 29 53.6 (9.3) 0.40 41.2 (9.0) −0.57
University degree 91 54.4 (8.4) 1.14 42.0 (12.1) −0.23
Maternal work status 147
Full-time homemaker 64 55.1 (8.1) Reference 42.7 (11.3) Reference
Part-time employment 37 50.4 (9.4) −4.69** 42.4 (11.9) −0.32
Full-time employment 46 55.7 (7.5) 0.57 40.8 (11.2) −1.86
Number of siblings 156
0 36 54.3 (8.1) Reference 37.4 (13.8) Reference
1 64 54.4 (7.5) 0.07 41.9 (11.3) 4.47*
2 or more 56 52.9 (9.9) −1.41 45.0 (9.6) 7.56**
Child order 156
The first child 72 54.4 (7.9) Reference 40.2 (11.7) Reference
Laterborn 84 53.3 (9.1) −1.02 43.5 (11.4) 3.24*
Child’s age 158
Under 1.5 years 24 53.3 (10.0) Reference 39.8 (13.2) Reference
1.5 to 7 years 69 54.6 (7.6) 1.31 42.4 (12.4) 2.63
7 to 13 years 40 52.7 (9.8) −0.63 43.7 (9.7) 3.94
13 years or over 25 53.0 (8.0) −0.29 39.2 (10.7) −0.55
Child’s gender 158
Female 136 53.9 (8.3) Reference 41.8 (11.6) Reference
Male 22 52.3 (10.4) −1.60 41.9 (12.1) 0.10
Child’s country of birth 158
North America 90 56.9 (5.9) Reference 41.5 (12.1) Reference
The United Kingdom 12 54.2 (10.9) −2.63 41.1 (8.4) −0.40
Australia and New Zealand 14 45.9 (7.4) −10.98** 43.6 (12.5) 2.07
Western Europe 29 47.6 (10.0) −9.21** 41.2 (12.2) −0.30
Others 13 52.9 (8.2) −3.93* 44.5 (9.7) 3.02
Mutation group 158
No functional protein 50 53.5 (8.0) Reference 43.0 (12.0) Reference
Missense/In-frame mutations 41 52.5 (9.9) −0.97 39.5 (10.8) −3.49
Truncations aa172 to aa781 44 53.7 (8.7) 0.23 42.0 (11.5) −0.98
Truncations after aa781 12 53.6 (7.4) 0.15 46.2 (9.1) 3.21
Mutations not grouped 11 58.5 (6.5) 5.05* 39.5 (15.1) −3.49
Feeding pattern 153
Oral intake only 114 54.3 (8.1) Reference 41.0 (12.2) Reference
Combination use 14 55.0 (6.8) 0.74 39.7 (9.4) −1.32
Enteral nutrition only 25 49.6 (11.0) −4.72** 47.4 (9.3) 6.37**
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Table 2 Univariate analysis for PCS and MCS of the SF-12v2 (n = 158) (Continued)
Dietary concerns 123
None 62 55.9 (7.3) Reference 41.9 (11.7) Reference
Occasional 39 51.8 (7.4) −4.14** 39.9 (12.6) −2.00
Frequent or constant 22 55.7 (8.0) −0.25 42.5 (10.3) 0.67
Floor sitting 129
No assistance 83 54.3 (7.6) Reference 41.7 (11.7) Reference
Some assistance 13 54.5 (7.8) 0.20 42.0 (12.5) 0.27
Maximal assistance/unable 33 51.3 (10.3) −3.02* 43.9 (10.6) 2.25
Taking 10 steps forward 126
No assistance 28 54.8 (7.2) Reference 41.6 (12.6) Reference
Some assistance 19 57.3 (7.2) 2.52 40.6 (14.3) −0.95
Maximal assistance/unable 79 52.4 (8.9) −2.37 43.2 (10.4) 1.63
Eye contact 148
No 78 53.0 (9.6) Reference 41.0 (12.0) Reference
Yes 70 54.6 (7.3) 1.57 42.5 (11.7) 1.54
Communication 129
No/Simple method 44 53.0 (9.0) Reference 44.1 (9.6) Reference
Complex gestures/vocalisation 58 53.5 (8.5) 0.52 41.2 (12.4) −2.91
Sign/Spoken language 27 55.0 (7.5) 1.98 42.1 (12.0) −2.02
Seizure frequency 146
Absent 12 53.7 (7.5) Reference 43.2 (11.3) Reference
Yearly/Monthly 15 53.4 (9.8) −0.33 41.3 (13.1) −1.82
Weekly 26 54.5 (6.7) 0.84 40.5 (10.7) −2.71
1 to 5 times a day 69 53.4 (8.9) −0.28 41.1 (12.7) −2.09
At least 5 times a day 24 54.2 (9.8) 0.49 45.6 (8.5) 2.47
Sleep difficulties 144
1.00 to 1.50 (1st quartile) 36 54.5 (8.3) Reference 45.2 (11.3) Reference
1.50 to 1.81 (2nd quartile) 38 54.1 (7.7) −0.46 42.7 (10.8) −2.58
1.81 to 2.17 (3rd quartile) 35 54.6 (7.5) 0.11 42.6 (11.2) −2.63
2.17 to 5.00 (4th quartile) 35 52.5 (10.1) −2.00 38.2 (12.1) −7.06**
Hospitalisation rate 146
0 to 0.38 (1st quartile) 34 52.9 (7.8) Reference 42.5 (10.2) Reference
0.38 to 0.86 (2nd quartile) 38 54.6 (8.3) 1.66 43.0 (12.2) 0.50
0.86 to 2.14 (3rd quartile) 36 53.1 (8.4) 0.23 39.9 (10.3) −2.60
2.14 to 13.70 (4th quartile) 38 54.0 (9.7) 1.11 43.7 (12.2) 1.19
Respite care 148
None 36 54.4 (8.3) Reference 42.7 (11.8) Reference
Formal only 21 52.0 (10.1) −2.41 44.9 (8.3) 2.21
Informal only 41 54.1 (8.6) −0.26 41.1 (13.9) −1.56
Both formal and informal 50 53.2 (8.4) −1.25 40.8 (10.4) −1.85
Financial difficulty 144
No 83 53.9 (8.5) Reference 44.0 (11.2) Reference
Yes 61 52.9 (8.9) −0.97 39.1 (11.6) −4.89**
*p <0.10 **p <0.05
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Family quality of life
Family quality of life was generally rated as satisfactory
with an overall score of 4.06 (SD 0.66). Among the sub-
scales, emotional wellbeing scores were lowest with a
mean of 3.50 (SD 0.97) and physical/material wellbeing
score were the highest with a mean of 4.32 (SD 0.70)
(Table 4). The univariate analysis demonstrated that the
child’s country of birth profoundly influenced the
BCFQOL scores, in which those from Western Europe
except the UK had the poorest family quality of life
Table 3 Multivariate analysis for PCS and MCS of the SF-12v2 and coefficients#1
Measure PCS MCS
Coefficient (95% CI) Coefficient (95% CI)
Feeding pattern Oral intake only Reference Reference
Combination use −1.01 (−5.63, 3.60) −1.49 (−8.36, 5.37)
Enteral nutrition only −4.51** (−8.12, −0.89) 6.67** (1.29 to 12.05)
Dietary concerns None Reference Reference
Occasional −4.98** (−8.11, −1.86) −0.88 (−5.97, 4.20)
Frequent or constant −1.81 (−5.51, 1.88) 0.30 (−5.72, 6.32)
Floor sitting No assistance Reference Reference
Some assistance 0.21 (−4.01, 4.42) −1.59 (−8.14, 4.96)
Maximal assistance/unable −2.27 (−5.44, 0.90) 1.03 (−3.89, 5.96)
Taking 10 steps forward No assistance Reference Reference
Some assistance 1.20 (−3.52, 5.91) −1.23 (−8.59, 6.14)
Maximal assistance/unable −1.85 (−5.34, 1.64) 0.15 (−5.30, 5.61)
Eye contact No Reference Reference
Yes 1.04 (−1.67, 3.75) 1.77 (−2.46, 6.00)
Communication No/Simple method Reference Reference
Complex gestures/vocalisation 0.45 (−2.58, 3.48) −0.85 (−5.42, 3.72)
Sign/Spoken language 1.03 (−3.00, 5.06) 0.14 (−5.93, 6.21)
Seizure frequency Absent Reference Reference
Yearly/Monthly −0.55 (−6.78, 5.68) −2.82 (−12.11, 6.46)
Weekly 0.42 (−5.41, 6.25) −3.42 (−12.11, 5.27)
1 to 5 times a day −0.76 (−5.88, 4.35) −1.90 (−9.52, 5.73)
At least 5 times a day −0.17 (−6.07, 5.72) 0.09 (−8.69, 8.88)
Sleep difficulties 1.00 to 1.50 (1st quartile) Reference Reference
1.50 to 1.81 (2nd quartile) 0.37 (−3.31, 4.04) −2.58 (−8.11, 2.95)
1.81 to 2.17 (3rd quartile) 2.12 (−1.65, 5.89) −2.57 (−8.25, 3.10)
2.17 to 5.00 (4th quartile) 1.02 (−2.88, 4.93) −8.04** (−13.91, −2.16)
Hospitalisation rate 0 to 0.38 (1st quartile) Reference Reference
0.38 to 0.86 (2nd quartile) −0.60 (−4.49, 3.30) −1.13 (−7.01, 4.73)
0.86 to 2.14 (3rd quartile) −2.27 (−6.42, 1.87) −4.22 (−10.47, 2.03)
2.14 to 13.70 (4th quartile) −1.15 (−5.31, 3.00) −0.88 (−7.15, 5.38)
Respite care None Reference Reference
Formal only 0.08 (−4.63, 4.79) 1.54 (−5.63, 8.69)
Informal only −0.80 (−4.57, 2.97) −1.54 (−7.26, 4.18)
Both formal and informal 1.00 (−2.79, 4.78) −2.73 (−8.48, 3.02)
Financial difficulty No Reference Reference
Yes −1.76 (−4.43, 0.92) −4.75** (−8.78, −0.71)
#1Adjusted for parent’s age (a continuous variable), parent’s qualification (a binary variable; university degree or lower), parent’s work status, number of siblings,
the first child, child’s age (a continuous variable) and child’s country of birth (a binary variable; North America or others)
**p <0.05
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Table 4 Univariate analysis for the BCFQOL Scale and coefficients (n = 149)
Measure Number of
observations















Under 30 years 11 Reference Reference Reference Reference Reference
30 to 40 years 75 −0.18 −0.13 0.07 0.07 −0.51**
40 years or over 57 −0.45* −0.34 0.06 −0.06 −0.71**
Parent’s qualification 137
11 or 12 years of school 24 Reference Reference Reference Reference Reference
TAFE/Technical certificate 28 0.18 0.10 0.05 0.36* −0.11
University degree 85 0.13 0.07 0.07 0.28* −0.11
Parent’s work status 138
Full-time homemaker 58 Reference Reference Reference Reference Reference
Part-time employment 34 −0.21 −0.32** 0.18 −0.19 −0.24
Full-time employment 46 0.03 −0.06 0.29 −0.03 −0.24
Number of siblings 147
0 29 Reference Reference Reference Reference Reference
1 64 −0.10 0.09 −0.17 0.13 −0.03
2 or more 54 0.04 0.20 −0.10 0.25 0.11
Child order 147
The first child 63 Reference Reference Reference Reference Reference
Laterborn 84 0.00 0.10 0.06 0.17 0.05
Child’s age 149
Under 1.5 years 21 Reference Reference Reference Reference Reference
1.5 to 7 years 67 0.06 −0.11 −0.32 −0.11 0.09
7 to 13 years 38 0.00 −0.12 −0.35 −0.11 0.05
13 years or over 23 −0.21 −0.34 −0.28 −0.36* −0.09
Child’s gender 149
Female 128 Reference Reference Reference Reference Reference
Male 21 0.13 0.07 0.00 0.01 −0.12
Child’s country of birth 149
North America 87 Reference Reference Reference Reference Reference
The United Kingdom 12 −0.02 −0.09 −0.05 −0.20 −0.25
Australia and New Zealand 13 −0.29 −0.48** −0.21 −0.45** −0.19
Western Europe 26 −0.51** −0.52** −0.43* −0.46** −0.61**
Others 11 −0.01 −0.18 −0.30 −0.32 −0.22
Mutation group 149
No functional protein 46 Reference Reference Reference Reference Reference
Missense/In-frame mutations 36 0.10 0.03 −0.16 0.01 −0.16
Truncations aa172 to aa781 45 0.05 −0.06 −0.16 0.02 −0.08
Truncations after aa781 12 0.07 0.06 0.11 0.16 0.06
Mutations not grouped 10 −0.01 −0.17 −0.06 −0.13 −0.31
Feeding pattern 144
Oral intake only 107 Reference Reference Reference Reference Reference
Combination use 14 −0.13 −0.16 −0.04 −0.34* −0.10
Enteral nutrition only 23 0.21 0.15 0.15 −0.02 0.06
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across subscales. Use of respite services was associated
adversely with every subscale, with lower BCFQOL scores
in family interaction, parenting, emotional wellbeing,
physical/material wellbeing and disability-related support
observed for those who had received both forms of the
services compared to non-users (coefficient = −0.50,
Table 4 Univariate analysis for the BCFQOL Scale and coefficients (n = 149) (Continued)
Dietary concerns 117
None 57 Reference Reference Reference Reference Reference
Occasional 38 −0.22 −0.34** −0.40* −0.40** −0.32**
Frequent or constant 22 0.18 −0.20 −0.02 −0.14 −0.20
Floor sitting 123
No assistance 77 Reference Reference Reference Reference Reference
Some assistance 13 0.07 0.07 0.29 −0.04 0.22
Maximal assistance/unable 33 0.17 0.19 0.15 0.06 0.15
Taking 10 steps forward 20
No assistance 26 Reference Reference Reference Reference Reference
Some assistance 17 0.15 −0.05 −0.03 −0.07 −0.04
Maximal assistance/unable 77 0.16 0.01 0.06 −0.02 0.01
Eye contact 139
No 71 Reference Reference Reference Reference Reference
Yes 68 −0.10 −0.11 −0.19 −0.09 −0.05
Communication 123
No/Simple method 42 Reference Reference Reference Reference Reference
Complex gestures/vocalisation 57 −0.16 −0.18 −0.38* −0.16 −0.24
Sign/Spoken language 24 0.06 0.10 −0.02 0.19 0.18
Seizure frequency 138
Absent 12 Reference Reference Reference Reference Reference
Yearly/Monthly 15 −0.28 −0.15 −0.07 −0.25 0.12
Weekly 25 −0.29 −0.03 0.14 −0.19 −0.03
1 to 5 times a day 62 −0.15 −0.00 0.11 −0.09 0.09
At least 5 times a day 24 −0.11 0.14 0.39 −0.06 0.22
Sleep difficulties 136
1.00 to 1.50 (1st quartile) 34 Reference Reference Reference Reference Reference
1.50 to 1.81 (2nd quartile) 37 −0.24 −0.23 −0.42* −0.33** −0.37**
1.81 to 2.17 (3rd quartile) 32 −0.19 −0.20 −0.34 −0.07 −0.14
2.17 to 5.00 (4th quartile) 33 −0.34* −0.34* −0.57** −0.41** −0.39**
Hospitalisation rate 139
0 to 0.38 (1st quartile) 31 Reference Reference Reference Reference Reference
0.38 to 0.86 (2nd quartile) 36 0.19 0.17 0.13 0.15 0.25
0.86 to 2.14 (3rd quartile) 35 0.01 −0.09 −0.42 −0.07 0.15
2.14 to 13.70 (4th quartile) 37 0.20 0.35** 0.06 0.07 0.16
Respite care 140
None 37 Reference Reference Reference Reference Reference
Formal only 21 −0.27 −0.18 −0.56** −0.16 −0.15
Informal only 35 −0.12 −0.19 −0.37 −0.27* −0.31*
Both formal and informal 47 −0.50** −0.35** −0.24 −0.34** −0.44**
Financial difficulty 137
No 76 Reference Reference Reference Reference Reference
Yes 61 0.03 −0.09 −0.57** −0.22* −0.09
*p < 0.10 **p < 0.05
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−0.35, −0.24, −0.34 and −0.44; p = 0.001, 0.028, 0.268,
0.027 and 0.011, respectively). There was a negative cor-
relation with the SDSC scores such that the families of the
children with the greatest sleep difficulties had the lowest
scores with all BCFQOL subscales, with the coefficients
of −0.34 for family interaction, −0.34 for parenting,
−0.57 for emotional wellbeing, −0.41 for physical/ma-
terial wellbeing and −0.39 for disability-related support
compared to the least sleep disturbances (p = 0.054,
0.057, 0.020, 0.015 and 0.040, respectively). Mothers
aged 40 years or more reported considerably poorer
quality of disability-related support, family inter-
action and parenting, compared with those aged
under 30 years (coefficients = −0.71, −0.45 and −0.34;
p = 0.005, 0.056 and 0.159, respectively). The multi-
variate model identified that those with the most ex-
tensive utilisation of respite care had the poorest
family quality of life with emotional wellbeing sub-
scale scores being the lowest for those who used for-
mal respite care in comparison with those who had
never received such services (Table 5). Particularly,
the effects on family interaction, emotional wellbeing,
physical/material wellbeing and disability-related support
were considerable (coefficients = −0.39, −0.36, −0.32 and
−0.39; p = 0.027, 0.127, 0.048 and 0.044, respectively). The
impact of child’s sleep difficulty was attenuated after
adjusting for PCS and MCS scores.
Discussion
Caregivers of children with the CDKL5 disorder experi-
enced considerable emotional burden. Despite better
physical wellbeing, emotional wellbeing (MCS 41.9, SD
11.6) was compromised in comparison with the US fe-
male norms and was poorer than has been demonstrated
in Australian research in both Rett syndrome [12] (MCS
42.4, SD 10.2) and Down syndrome [11] (MCS 45.2, SD
10.6). In contrast, a large proportion of mothers in the
international CDKL5 disorder sample were from the US,
and generally younger than those in the Australian stud-
ies [11, 12], factors which may also have some bearing
on the findings.
Emotional wellbeing of primary care givers was par-
ticularly poor when the child was an only child, the
child’s co-occurring sleep disturbances were severe, and
the family had faced financial hardships to meet the
child’s healthcare needs. These associations are broadly
consistent with findings of most previous research.
Poor maternal sleep quality, often a sequela of child’s
sleep disturbances, has been shown to be an important
predictor of depression in mothers of children with
developmental disabilities, mostly autism spectrum
disorder [23–27] or cerebral palsy [28]. Moreover, a
similar relationship to that we identified with financial
hardship was demonstrated in a Canadian study in-
volving mothers with a child with a developmental
disability [29].
Our study reveals some unique findings. Firstly, men-
tal health was least impaired in mothers caring for a
child who was totally tube fed, whereas this was the
group with the poorest physical health. The literature
has shown variability in parent’s experiences for those
with a child with a disability after the child’s gastros-
tomy placement, although enhancement in nutritional
status has been reported [30–33]. Parents have reported
less burden of care at mealtimes, reduced stress that
their child is inadequately nourished, and relief that
medications are consistently delivered, consequently
improving their emotional wellbeing [30–34]. In a pre-
vious study with primary caregivers of a child with Rett
syndrome we found that there was general satisfaction
with outcomes following gastrostomy insertion [30].
This was related to improved well-being and nutritional
status of the child and for the parent reduced care de-
mands and less concern about feeding and the delivery
of medication [30]. In this study of the CDKL5 disorder,
it is likely that some children may have had the gastros-
tomy placement in order to facilitate the provision of a
ketogenic diet [35], which might have helped control
seizures and in turn ease emotional burden of care for
the parents. Although primary caregiver’s physical
health was not adversely affected by gastrostomy place-
ment in those with a child with cerebral palsy [36], in-
creased demands or excessive weight gain of the child
could be contributing to mothers’ physical burden in our
study. Thus some deterioration in caregiver physical
health may accompany better emotional health, which has
been a consequence of less mealtime stress and improved
child well-being.
Secondly, while a slight improvement in physical
wellbeing was demonstrated, respite care use did not
have a positive impact on the mental health of the pri-
mary caregivers. Furthermore, families who had uti-
lised these services were less satisfied with every
aspect of their family quality of life compared with
non-users. Despite contrasting findings from a system-
atic review [37], individual studies have shown that
service utilisation either had no positive effect [29] or
was negatively associated with carer’s emotional health
[38, 39]. Our longitudinal study involving families with
a child with Rett syndrome found that respite care use
did not improve parental emotional health and was as-
sociated with worse physical health over two years of
follow-up [40]. Furthermore, in other research in-
creased family needs for support have been reported
to be associated with poorer family quality of life [41].
Our findings might suggest that needs for respite care
are not being met for some families and that the
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current framework for service delivery is not enhan-
cing parental wellbeing or family quality of life. How-
ever, this issue warrants further investigation, possibly
using either a longitudinal study design and/or quali-
tiative methods.
Thirdly, mothers in the youngest age group experi-
enced the most impaired emotional health, possibly
related to the recency of receiving their child’s diagnosis,
a time when they could be experiencing overwhelming
fear and loneliness [42]. However, establishing a diagnosis
Table 5 Multivariate analysis for the BCFQOL Scale and coefficients#1






Feeding pattern Oral intake only Reference Reference Reference Reference Reference
Combination use −0.12 −0.16 0.13 −0.16 0.13
Enteral nutrition only 0.07 0.02 -0.06 -0.03 -0.06
Dietary concerns None Reference Reference Reference Reference Reference
Occasional −0.15 −0.25 −0.08 −0.25 −0.19
Frequent or constant −0.29 −0.29 0.19 −0.19 −0.26
Floor sitting No assistance Reference Reference Reference Reference Reference
Some assistance −0.02 0.05 0.42 −0.10 0.17
Maximal assistance/Unable 0.17 0.16 0.19 0.14 0.20
Taking 10 steps forward No assistance Reference Reference Reference Reference Reference
Some assistance 0.21 −0.03 0.13 0.02 0.09
Maximal assistance/Unable 0.18 0.08 0.25 0.09 0.07
Eye contact No Reference Reference Reference Reference Reference
Yes −0.16 −0.18 −0.19 −0.12 −0.05
Communication No/Simple method Reference Reference Reference Reference Reference
Complex gestures/vocalisation −0.12 −0.11 −0.33* −0.11 −0.15
Sign/Spoken language −0.02 −0.02 −0.31 0.03 0.06
Seizure frequency Absent Reference Reference Reference Reference Reference
Yearly/Monthly −0.28 −0.06 0.40 −0.15 0.26
Weekly −0.12 0.13 0.57* −0.05 0.26
1 to 5 times a day −0.25 −0.06 0.13 −0.06 0.18
At least 5 times a day −0.07 0.14 0.53 0.06 0.35
Sleep difficulties 1.00 to 1.50 (1st quartile) Reference Reference Reference Reference Reference
1.50 to 1.81 (2nd quartile) −0.10 −0.08 −0.28 −0.09 −0.28
1.81 to 2.17 (3rd quartile) −0.06 −0.03 −0.26 0.08 −0.10
2.17 to 5.00 (4th quartile) −0.15 −0.09 −0.26 −0.16 −0.23
Hospitali-sation rate 0 to 0.38 (1st quartile) Reference Reference Reference Reference Reference
0.38 to 0.86 (2nd quartile) 0.14 0.07 0.09 −0.01 0.21
0.86 to 2.14 (3rd quartile) −0.07 −0.18 −0.37 −0.22 0.08
2.14 to 13.70 (4th quartile) 0.10 0.24 0.09 0.03 0.13
Respite care None Reference Reference Reference Reference Reference
Formal only −0.29 −0.18 −0.72** −0.07 −0.01
Informal only −0.06 −0.20 −0.47** −0.23 −0.28
Both formal and informal −0.39** −0.26 −0.36 −0.32** −0.39**
Financial difficulty No Reference Reference Reference Reference Reference
Yes 0.11 0.04 −0.27 0.03 0.02
#1Adjusted for parent’s age (a continuous variable), parent’s qualification (a binary variable; university degree or lower), parent’s work status, number of siblings,
the first child, child’s age (a continuous variable), child’s country of birth (a binary variable; North America or others) and the scores of PCS and MCS
(continuous variables)
*p <0.10 **p <0.05
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is imperative so that families can clarify their child’s ex-
pected life course and gain disease-specific family support
[43]. Parents of a child with intellectual disability reported
their wellbeing as better when the child had received a
definite diagnosis [17]. As the CDKL5 gene testing has be-
come available over the last decade, some of older primary
caregivers in this study might have felt greatly relieved
when their adult child eventually received a clear diagno-
sis. That said even in the general population mental health
scores do improve with age [20], but for those with a
CDKL5-affected child, we showed that the mean MCS
score was consistently poorer across all age groups.
Lastly, family quality of life was strongly mediated by
primary caregiver’s health status. The mother’s report of
family quality of life has been assessed in most studies
[16], and mothers under stress are more likely to con-
sider their family quality of life as poorer [15]. In our
study, adjustment for the SF-12v2 scores indicated that
child’s sleep difficulty had less impact on the whole fam-
ily than on the primary carer. Controlling for maternal
health would be of use to verify pathways from potential
predictors to family quality of life.
We were surprised that there were no strong associa-
tions between the frequency of seizures or the attain-
ment of gross motor and communication skills and
family outcomes, given the major burden of epilepsy and
the severe physical and intellectual impairment in the
CDKL5 disorder. Previous studies on the effect of seiz-
ure control on maternal mental health have had mixed
findings although mostly undertaken in children who
were otherwise healthy [44–48]. The marked intellectual
disability and various comorbidities among children with
the CDKL5 disorder may lessen the influence of seizures
alone on the primary caregiver’s health.
Finally, we did not find any association between the
rate of hospitalisations and primary caregiver health or
family quality of life. In our study, all hospitalisations
experienced by the child with the CDKL5 disorder over
the life course were included, whereas the outcomes
related to current status. We therefore may not be able
to observe any true relationships.
Our study has several limitations. First, we used a
cross-sectional study design and because of the absence
of longitudinal data we were restricted to the reporting
of associations rather than causal relationships. Sec-
ondly, despite the growth of our international database,
the ICDD is not a population-based study. Hence, while
remarkable heterogeneity in the carer’s physical health
and family quality of life were found according to child’s
country of birth, it might be explained by the uneven
distribution of participants as well as voluntary partici-
pation. Thirdly, we did not account for the child’s age
when a diagnosis was made. Time intervals from when
parents first had concerns about their child to the age at
diagnosis and from the age at diagnosis to the present
might influence the primary caregiver’s emotional well-
being. Fourthly, family quality of life was reported solely
by the primary caregiver although adjustment for the
SF-12v2 scores would have helped to counteract any
confounding effect.
Conclusions
Despite its shortcomings, we believe that this study
provides important insights into primary caregiver’s
wellbeing and family quality of life among families with
a child with a severe genetic disorder, previously difficult
to study because of its rarity. Child’s feeding methods
and sleep difficulties, and experiences of financial hard-
ship were associated with primary caregiver’s wellbeing,
whereas use of respite care services was the principal
correlate with family quality of life after controlling for
the carer’s health among families with a child with the
CDKL5 disorder included in this study. To date, min-
imal attention has been given to families with a child
living with a rare genetic disorder. Although we still
acknowledge the need for further longitudinal investiga-
tion, the current research has only been possible for the
CDKL5 disorder through the implementation and devel-
opment of a worldwide database.
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